Selection of mammalian cell mutants in sphingolipid biosynthesis.
Hanada
K
K
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.
Nishijima
M
M
D000818:Animals; D001345:Autoradiography; D016466:CHO Cells; D002250:Carbon Radioisotopes; D002460:Cell Line; D002855:Chromatography, Thin Layer / Q000379:methods; D006224:Cricetinae; D004351:Drug Resistance / Q000235:genetics; D005020:Ethyl Methanesulfonate; D008322:Mammals; D016296:Mutagenesis; D011506:Proteins / Q000633:toxicity; D012694:Serine / Q000378:metabolism; D013107:Sphingolipids / Q000302:isolation & purification / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism*; D014118:Toxins, Biological; D014662:Vasoconstrictor Agents / Q000633:toxicity
D002250:Carbon Radioisotopes; D011506:Proteins; D013107:Sphingolipids; D013109:Sphingomyelins; D014118:Toxins, Biological; D014662:Vasoconstrictor Agents; C107040:lysenin; D012694:Serine; D005020:Ethyl Methanesulfonate